Healthcare Industry News: intervertebral body fusion
News Release - October 4, 2011
Integra LifeSciences Launches an Anterior Cervical Plating SystemNovel Locking Mechanism Helps Limit Uncertainty in Treatment of Cervical Spine
PLAINSBORO, N.J., Oct. 4, 2011 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART ) today announced the U.S. commercial market introduction of the Cordant(TM) Anterior Cervical Plating System, expanding Integra's spine product portfolio to include three anterior cervical plating solutions. The Cordant(TM) Anterior Cervical Plating System provides temporary stability during spinal fusion procedures for patients suffering from disc disease or trauma.
The Cordant(TM) Anterior Cervical Plate System features a narrow hour-glass plate design, which provides excellent lateral graft visualization and potentially reduces the amount of tissue retraction required for implantation. This plate design may provide a better fit for smaller stature patients. The novel tri-cam locking mechanism and instrumentation provide a streamlined approach to anterior cervical fusion. The screwdriver handle is ergonomically designed with three flats that are orientated to the three flats on the locking screw head, providing easy alignment and locking confirmation, limiting uncertainty with simple innovative design.
"Surgeons need options to accommodate a broad range of patient anatomy," said Brian Larkin, Global President, Spine and Orthobiologics, and Head of Strategic Development for Integra. "We are now better equipped to meet their needs by offering three anterior cervical plates."
It is estimated that 90% of all cervical fixation procedures are performed with an anterior approach. In 2011, surgeons will perform an estimated 300,000 anterior cervical fixation procedures, with a market size of approximately $800 million.
Integra sells the Cordant(TM) Anterior Cervical Plate System in the U.S., and is a leading provider of fusion implants and orthobiologics used in spinal surgeries. Integra's Cervical portfolio also includes the Manta Ray(TM) Anterior Cervical Plate, Sonoma(TM) Anterior Cervical Plate, Atoll(TM) Posterior Cervical System, Sierra(TM) Posterior Fusion System, Vu cPOD(TM) intervertebral body fusion Device, Cambria(TM) Intervertebral Body Device, Capistrano(TM) Allograft Spacer, and the Zuma-CTM Anterior Cervical Fixation System.
Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive, and general surgery. For more information, please visit www.integralife.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the products and services provided by Integra. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of surgical professionals to use Integra products may affect the prospects for their use in surgical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2010 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
Source: Integra LifeSciences
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.